ETHZilla Corp
NASDAQ:ETHZ

Watchlist Manager
ETHZilla Corp Logo
ETHZilla Corp
NASDAQ:ETHZ
Watchlist
Price: 5.24 USD -0.57% Market Closed
Market Cap: $101.1m

Net Margin

-5 671.8%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-5 671.8%
=
Net Income
$-233.1m
/
Revenue
$4.1m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-5 671.8%
=
Net Income
$-233.1m
/
Revenue
$4.1m

Peer Comparison

Country Company Market Cap Net
Margin
US
ETHZilla Corp
NASDAQ:ETHZ
101.1m USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
387.5B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.5B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
168.8B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.2B USD
Loading...

Market Distribution

Lower than 95% of companies in the United States of America
Percentile
5th
Based on 15 072 companies
5th percentile
-5 671.8%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

ETHZilla Corp
Glance View

Market Cap
101.1m USD
Industry
Biotechnology

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palo Alto, California. The company went IPO on 2017-06-07. This strategy is built for the community, by the community. Through its partnership with Electric Capital, ETHZilla's treasury strategy aims to pursue a differentiated yield generation program meant to outperform traditional ETH staking. The firm has also been evolving its business towards software-enabled gaming and entertainment. In addition to its ETH treasury strategy, the Company continues to maintain and accelerate the deployment and development of its gaming initiatives.

ETHZ Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-5 671.8%
=
Net Income
$-233.1m
/
Revenue
$4.1m
What is ETHZilla Corp's current Net Margin?

The current Net Margin for ETHZilla Corp is -5 671.8%, which is in line with its 3-year median of -5 671.8%.

How has Net Margin changed over time?

Over the last 0 months, ETHZilla Corp’s Net Margin has decreased from -5 671.8% to -5 671.8%. During this period, it reached a low of -5 671.8% on Oct 30, 2025 and a high of -5 671.8% on Oct 30, 2025.

Back to Top